U.S. FDA gives early approval to Sarepta's newest DMD treatment

The U.S. Food and Drug Administration on Thursday granted an early approval to Sarepta Therapeutics Inc's second treatment for Duchenne muscular dystrophy (DMD).


from Reuters: Health News https://ift.tt/36ssJEi
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Second round

In 2021, I lost about 75 lbs in a year naturally. I became a CO and worked 60-80 weeks, second shift, ate and went right to bed, had hardly...